{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:44:25Z","timestamp":1785818665136,"version":"3.56.0"},"reference-count":69,"publisher":"China Science Publishing & Media Ltd.","issue":"7","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.3724\/abbs.2026048","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:41:07Z","timestamp":1773654067000},"page":"1568-1578","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["MerTK inhibition by UNC569 triggers DNA damage and JNK\/p38 MAPK cascade-driven apoptosis in pancreatic cancer"],"prefix":"10.3724","volume":"58","author":[{"given":"Meng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"Rahib L","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united states. Cancer Res, 2014, 74: 2913-2921.","journal-title":"Cancer Res"},{"key":"CITATION3","unstructured":"Wang X, Cheng H, Liu C, Yu X. New progress in basic research, clinical diagnosis and treatment of pancreatic cancer in 2022.  Chin J Cancer . 2023, 33: 1\u201313 ."},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/pcmr.12110","volume":"26","author":"Tworkoski KA","year":"2013","unstructured":"Tworkoski KA, Platt JT, Bacchiocchi A, Bosenberg M, Boggon TJ, Stern DF. MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell Melanoma Res, 2013, 26: 527-541.","journal-title":"Pigment Cell Melanoma Res"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1038\/onc.2012.355","volume":"32","author":"Linger RMA","year":"2013","unstructured":"Linger RMA, Cohen RA, Cummings CT, Sather S, Migdall-Wilson J, Middleton DHG, Lu X. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene, 2013, 32: 3420-3431.","journal-title":"Oncogene"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1158\/1535-7163.MCT-09-0707","volume":"9","author":"Keating AK","year":"2010","unstructured":"Keating AK, Kim GK, Jones AE, Donson AM, Ware K, Mulcahy JM, Salzberg DB. Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity. Mol Cancer Ther, 2010, 9: 1298-1307.","journal-title":"Mol Cancer Ther"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.18632\/oncotarget.1793","volume":"5","author":"Knubel KH","year":"2014","unstructured":"Knubel KH, Pernu BM, Sufit A, Nelson S, Pierce AM, Keating AK. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme. Oncotarget, 2014, 5: 1338-1351.","journal-title":"Oncotarget"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.redox.2022.102366","volume":"54","author":"Liu Y","year":"2022","unstructured":"Liu Y, Lan L, Li Y, Lu J, He L, Deng Y, Fei M.  N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth . Redox Biol, 2022, 54:","journal-title":"Redox Biol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"105727","DOI":"10.18632\/oncotarget.22394","volume":"8","author":"Kim JE","year":"2017","unstructured":"Kim JE, Kim Y, Li G, Kim ST, Kim K, Park SH, Park JO. MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines. Oncotarget, 2017, 8: 105727-105734.","journal-title":"Oncotarget"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"105278","DOI":"10.1016\/j.ebiom.2024.105278","volume":"107","author":"V\u00e1zquez-Bell\u00f3n N","year":"2024","unstructured":"V\u00e1zquez-Bell\u00f3n N, Mart\u00ednez-Bosch N, Garc\u00eda de Frutos P, Navarro P. Hallmarks of pancreatic cancer: spotlight on TAM receptors. eBioMedicine, 2024, 107:","journal-title":"eBioMedicine"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-023-01467-9","volume":"16","author":"Fan J","year":"2023","unstructured":"Fan J, Yu Y, Yan L, Yuan Y, Sun B, Yang D, Liu N. GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. J Hematol Oncol, 2023, 16:","journal-title":"J Hematol Oncol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1158\/1535-7163.MCT-13-0040","volume":"12","author":"Christoph S","year":"2013","unstructured":"Christoph S, DeRyckere D, Schlegel J, Frazer JK, Batchelor LA, Trakhimets AY, Sather S.  UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo . Mol Cancer Ther, 2013, 12: 2367-2377.","journal-title":"Mol Cancer Ther"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1021\/jm500749d","volume":"57","author":"Zhang W","year":"2014","unstructured":"Zhang W, DeRyckere D, Hunter D, Liu J, Stashko MA, Minson KA, Cummings CT. UNC2025, a potent and orally bioavailable MER\/FLT3 dual inhibitor. J Med Chem, 2014, 57: 7031-7041.","journal-title":"J Med Chem"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejmech.2013.03.035","volume":"65","author":"Liu J","year":"2013","unstructured":"Liu J, Zhang W, Stashko MA, DeRyckere D, Cummings CT, Hunter D, Yang C. UNC1062, a new and potent Mer inhibitor. Eur J Med Chem, 2013, 65: 83-93.","journal-title":"Eur J Med Chem"},{"key":"CITATION15","doi-asserted-by":"crossref","unstructured":"Koda Y, Itoh M, Tohda S. Effects of MERTK inhibitors UNC569 and UNC1062 on the growth of acute myeloid leukaemia cells.  Anticancer Res . 2018, 38: 199\u2013204 .","DOI":"10.21873\/anticanres.12208"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.18632\/oncotarget.3156","volume":"6","author":"Lee-Sherick AB","year":"2015","unstructured":"Lee-Sherick AB, Zhang W, Menachof KK, Hill AA, Rinella S, Kirkpatrick G, Page LS. Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia. Oncotarget, 2015, 6: 6722-6736.","journal-title":"Oncotarget"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1158\/0008-5472.CAN-16-2675","volume":"77","author":"Vouri M","year":"2017","unstructured":"Vouri M, Hafizi S. TAM receptor tyrosine kinases in cancer drug resistance. Cancer Res, 2017, 77: 2775-2778.","journal-title":"Cancer Res"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"e150517","DOI":"10.1172\/JCI150517","volume":"132","author":"Yan D","year":"2022","unstructured":"Yan D, Huelse JM, Kireev D, Tan Z, Chen L, Goyal S, Wang X. MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer. J Clin Invest, 2022, 132:","journal-title":"J Clin Invest"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"101415","DOI":"10.1016\/j.xcrm.2024.101415","volume":"5","author":"Wang S","year":"2024","unstructured":"Wang S, Zhu L, Li T, Lin X, Zheng Y, Xu D, Guo Y. Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma. Cell Rep Med, 2024, 5:","journal-title":"Cell Rep Med"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1093\/nar\/gkn550","volume":"36","author":"Kinner A","year":"2008","unstructured":"Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res, 2008, 36: 5678-5694.","journal-title":"Nucleic Acids Res"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41581-022-00671-z","volume":"19","author":"Garaycoechea JI","year":"2023","unstructured":"Garaycoechea JI, Quinlan C, Luijsterburg MS. Pathological consequences of DNA damage in the kidney. Nat Rev Nephrol, 2023, 19: 229-243.","journal-title":"Nat Rev Nephrol"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41392-023-01548-8","volume":"8","author":"Li Q","year":"2023","unstructured":"Li Q, Qian W, Zhang Y, Hu L, Chen S, Xia Y. A new wave of innovations within the DNA damage response. Sig Transduct Target Ther, 2023, 8:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","volume":"24","author":"Drew Y","year":"2025","unstructured":"Drew Y, Zenke FT, Curtin NJ. DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications. Nat Rev Drug Discov, 2025, 24: 19-39.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1158\/1541-7786.MCR-20-0414","volume":"19","author":"Ramkumar K","year":"2021","unstructured":"Ramkumar K, Stewart CA, Cargill KR, Della Corte CM, Wang Q, Shen L, Diao L. AXL inhibition induces DNA damage and replication stress in non-small cell lung cancer cells and promotes sensitivity to ATR inhibitors. Mol Cancer Res, 2021, 19: 485-497.","journal-title":"Mol Cancer Res"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12943-023-01887-8","volume":"22","author":"Xu L","year":"2023","unstructured":"Xu L, Ma X, Zhang X, Zhang C, Zhang Y, Gong S, Wu N. hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1\/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma. Mol Cancer, 2023, 22:","journal-title":"Mol Cancer"},{"key":"CITATION26","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2025137","author":"Wang H","year":"2025, doi: 10.3724\/abbs.2025137","unstructured":"Wang H, Xie H, Lin Y, Zhang Z, Zhang M, Zhao J, Zhao Q. L-arginine synergistic with 5-fluorouracil intervenes in DNA damage repair via the DNA-PKcs\/ATM\/ATR pathway in hepatocellular carcinoma cells. Acta Biochim Biophys Sin, 2025, doi: 10.3724\/abbs.2025137,","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13045-018-0584-6","volume":"11","author":"Shi C","year":"2018","unstructured":"Shi C, Li X, Wang X, Ding N, Ping L, Shi Y, Mi L. The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma. J Hematol Oncol, 2018, 11:","journal-title":"J Hematol Oncol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.3390\/ijms25136991","volume":"25","author":"Malamos P","year":"2024","unstructured":"Malamos P, Papanikolaou C, Gavriatopoulou M, Dimopoulos MA, Terpos E, Souliotis VL. The interplay between the DNA damage response (DDR) network and the mitogen-activated protein kinase (MAPK) signaling pathway in multiple myeloma. Int J Mol Sci, 2024, 25:","journal-title":"Int J Mol Sci"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.4251\/wjgo.v16.i7.3230","volume":"16","author":"Yu M","year":"2024","unstructured":"Yu M, Chen Q, Lu YP. Aldehyde dehydrogenase 2 family member repression promotes colorectal cancer progression by JNK\/p38 MAPK pathways-mediated apoptosis and DNA damage. World J Gastrointest Oncol, 2024, 16: 3230-3240.","journal-title":"World J Gastrointest Oncol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1042\/BJ20061778","volume":"405","author":"Jones EV","year":"2007","unstructured":"Jones EV, Dickman MJ, Whitmarsh AJ. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J, 2007, 405: 617-623.","journal-title":"Biochem J"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1038\/sj.onc.1209737","volume":"25","author":"Winograd-Katz SE","year":"2006","unstructured":"Winograd-Katz SE, Levitzki A. Cisplatin induces PKB\/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene, 2006, 25: 7381-7390.","journal-title":"Oncogene"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1007\/s00204-019-02579-3","volume":"93","author":"Li Y","year":"2019","unstructured":"Li Y, Lu J, Chen Q, Han S, Shao H, Chen P, Jin Q. Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling. Arch Toxicol, 2019, 93: 3367-3383.","journal-title":"Arch Toxicol"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"25737","DOI":"10.1074\/jbc.M114.570838","volume":"289","author":"Nguyen KQN","year":"2014","unstructured":"Nguyen KQN, Tsou WI, Calarese DA, Kimani SG, Singh S, Hsieh S, Liu Y. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity. J Biol Chem, 2014, 289: 25737-25749.","journal-title":"J Biol Chem"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"4197815","DOI":"10.1155\/2016\/4197815","volume":"2016","author":"Bazhin AV","year":"2016","unstructured":"Bazhin AV, Philippov PP, Karakhanova S. Reactive oxygen species in cancer biology and anticancer therapy. Oxid Med Cell Longev, 2016, 2016:","journal-title":"Oxid Med Cell Longev"},{"key":"CITATION35","doi-asserted-by":"crossref","unstructured":"Pinto DMS, Flaus A. Structure and function of histone H2AX.  Subcell Biochem  2010, 50: 55\u201378 .","DOI":"10.1007\/978-90-481-3471-7_4"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/odi.13950","volume":"29","author":"Vo TTT","year":"2023","unstructured":"Vo TTT, Wee Y, Cheng HC, Wu CZ, Chen YL, Tuan VP, Liu JF. Surfactin induces autophagy, apoptosis, and cell cycle arrest in human oral squamous cell carcinoma. Oral Dis, 2023, 29: 528-541.","journal-title":"Oral Dis"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.pharmr.2024.100030","volume":"77","author":"Glaviano A","year":"2025","unstructured":"Glaviano A, Singh SK, Lee EHC, Okina E, Lam HY, Carbone D, Reddy EP. Cell cycle dysregulation in cancer. Pharmacol Rev, 2025, 77:","journal-title":"Pharmacol Rev"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.devcel.2010.02.013","volume":"18","author":"Gavet O","year":"2010","unstructured":"Gavet O, Pines J. Progressive activation of cyclinb1-cdk1 coordinates entry to mitosis. Dev Cell, 2010, 18: 533-543.","journal-title":"Dev Cell"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1615\/CritRevEukaryotGeneExpr.v26.i1.60","volume":"26","author":"Parveen A","year":"2016","unstructured":"Parveen A, Akash MSH, Rehman K, Kyunn WW. Dual role of p21 in the progression of cancer and its treatment. Crit Rev Eukaryot Gene Expr, 2016, 26: 49-62.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1038\/s41467-023-38771-4","volume":"14","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Yang Y, Yang F, Liu X, Zhan P, Wu J, Wang X. HDAC9-mediated epithelial cell cycle arrest in G2\/M contributes to kidney fibrosis in male mice. Nat Commun, 2023, 14:","journal-title":"Nat Commun"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.3390\/molecules28135047","volume":"28","author":"Wang Y","year":"2023","unstructured":"Wang Y, Li Y, Liu D, Zheng D, Li X, Li C, Huang C. A potential anti-glioblastoma compound LH20 induces apoptosis and arrest of human glioblastoma cells via CDK4\/6 inhibition. Molecules, 2023, 28:","journal-title":"Molecules"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/abbs\/gmw097","volume":"48","author":"Liang C","year":"2016","unstructured":"Liang C, Qin Y, Zhang B, Ji S, Shi S, Xu W, Liu J. Energy sources identify metabolic phenotypes in pancreatic cancer. Acta Biochim Biophys Sin, 2016, 48: 969-979.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41388-024-02991-9","volume":"43","author":"Xiong Q","year":"2024","unstructured":"Xiong Q, Zhang Y, Xu Y, Yang Y, Zhang Z, Zhou Y, Zhang S. tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c\u2011MYC transcription. Oncogene, 2024, 43: 1274-1287.","journal-title":"Oncogene"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.7150\/ijbs.76756","volume":"19","author":"Ji Q","year":"2023","unstructured":"Ji Q, Li H, Cai Z, Yuan X, Pu X, Huang Y, Fu S. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Int J Biol Sci, 2023, 19: 1894-1909.","journal-title":"Int J Biol Sci"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"Zheng X","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature, 2015, 527: 525-530.","journal-title":"Nature"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"Dhanasekaran R","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol, 2022, 19: 23-36.","journal-title":"Nat Rev Clin Oncol"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00109-016-1452-x","volume":"95","author":"Lin X","year":"2016","unstructured":"Lin X, Sun R, Zhao X, Zhu D, Zhao X, Gu Q, Dong X. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc\/snail\/Bax signaling. J Mol Med, 2016, 95: 53-67.","journal-title":"J Mol Med"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13046-023-02698-x","volume":"42","author":"Yang J","year":"2023","unstructured":"Yang J, Ren B, Ren J, Yang G, Fang Y, Wang X, Zhou F. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. J Exp Clin Cancer Res, 2023, 42:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"114908","DOI":"10.1016\/j.intimp.2025.114908","volume":"159","author":"Lee Y","year":"2025","unstructured":"Lee Y, Loh JK, Ko HJ, Chen WC, Su YF, Tsai TH, Huang FL. 6-Gingerol overcomes TMZ resistance in GBM by suppressing EMT and cell migration via the PI3K\/Akt\/\u03b2-catenin\/c-Myc pathway. Int Immunopharmacol, 2025, 159:","journal-title":"Int Immunopharmacol"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2010.01.013","volume":"293","author":"Cho KB","year":"2010","unstructured":"Cho KB, Cho MK, Lee WY, Kang KW. Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells. Cancer Lett, 2010, 293: 230-239.","journal-title":"Cancer Lett"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00204-022-03421-z","volume":"97","author":"Tuli HS","year":"2023","unstructured":"Tuli HS, Kaur J, Vashishth K, Sak K, Sharma U, Choudhary R, Behl T. Molecular mechanisms behind ROS regulation in cancer: a balancing act between augmented tumorigenesis and cell apoptosis. Arch Toxicol, 2023, 97: 103-120.","journal-title":"Arch Toxicol"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3724\/abbs.2024040","volume":"56","author":"Deng Y","year":"2024","unstructured":"Deng Y, Li Y, Yang M, Gao Y, Luo X, Chen H, Guo M. Carfilzomib activates ER stress and JNK\/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells. Acta Biochim Biophys Sin, 2024, 56: 697-708.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"107577","DOI":"10.1016\/j.pharmthera.2020.107577","volume":"213","author":"Huelse JM","year":"2020","unstructured":"Huelse JM, Fridlyand DM, Earp S, DeRyckere D, Graham DK. MERTK in cancer therapy: targeting the receptor tyrosine kinase in tumor cells and the immune system. Pharmacol Ther, 2020, 213:","journal-title":"Pharmacol Ther"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"Groelly FJ","year":"2023","unstructured":"Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M. Targeting DNA damage response pathways in cancer. Nat Rev Cancer, 2023, 23: 78-94.","journal-title":"Nat Rev Cancer"},{"key":"CITATION55","doi-asserted-by":"crossref","unstructured":"Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage.  Methods Mol Biol Clifton NJ . 2012, 920: 613\u2013626 .","DOI":"10.1007\/978-1-61779-998-3_40"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/cr.2015.67","volume":"25","author":"Singh I","year":"2015","unstructured":"Singh I, Ozturk N, Cordero J, Mehta A, Hasan D, Cosentino C, Sebastian C. High mobility group protein-mediated transcription requires DNA damage marker \u03b3-H2AX. Cell Res, 2015, 25: 837-850.","journal-title":"Cell Res"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"16011","DOI":"10.1038\/cddiscovery.2016.11","volume":"2","author":"Ding D","year":"2016","unstructured":"Ding D, Zhang Y, Wang J, Zhang X, Gao Y, Yin L, Li Q. Induction and inhibition of the pan-nuclear gamma-H2AX response in resting human peripheral blood lymphocytes after X-ray irradiation. Cell Death Discov, 2016, 2:","journal-title":"Cell Death Discov"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"Bonner WM","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. \u03b3H2AX and cancer. Nat Rev Cancer, 2008, 8: 957-967.","journal-title":"Nat Rev Cancer"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1128\/MCB.02077-06","volume":"27","author":"Fink M","year":"2007","unstructured":"Fink M, Imholz D, Thoma F. Contribution of the serine 129 of histone H2A to chromatin structure. Mol Cell Biol, 2007, 27: 3589-3600.","journal-title":"Mol Cell Biol"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/15384101.2014.1000134","volume":"14","author":"Gire V","year":"2015","unstructured":"Gire V, Duli\u0107 V. Senescence from G2 arrest, revisited. Cell Cycle, 2015, 14: 297-304.","journal-title":"Cell Cycle"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","volume":"92","author":"Kyriakis JM","year":"2012","unstructured":"Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev, 2012, 92: 689-737.","journal-title":"Physiol Rev"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"a011254","DOI":"10.1101\/cshperspect.a011254","volume":"4","author":"Morrison DK","year":"2012","unstructured":"Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol, 2012, 4:","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"Cargnello M","year":"2011","unstructured":"Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev, 2011, 75: 50-83.","journal-title":"Microbiol Mol Biol Rev"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1109\/TNB.2023.3238687","volume":"22","author":"Li CH","year":"2023","unstructured":"Li CH, Lim SH, Jeong YI, Ryu HH, Jung S. Synergistic effects of radiotherapy with JNK inhibitor-incorporated nanoparticle in an intracranial lewis lung carcinoma mouse models. IEEE Transon NanoBiosci, 2023, 22: 845-854.","journal-title":"IEEE Transon NanoBiosci"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.18632\/oncotarget.7018","volume":"7","author":"Xie D","year":"2016","unstructured":"Xie D, Wu X, Lan L, Shangguan F, Lin X, Chen F, Xu S. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK\/p38MAPK signaling and reducing cellular bioenergetics. Oncotarget, 2016, 7: 11609-11624.","journal-title":"Oncotarget"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000488433","volume":"46","author":"Lin CL","year":"2018","unstructured":"Lin CL, Lee CH, Chen CM, Cheng CW, Chen PN, Ying TH, Hsieh YH. Protodioscin induces apoptosis through ROS-mediated endoplasmic reticulum stress via the JNK\/p38 activation pathways in human cervical cancer cells. Cell Physiol Biochem, 2018, 46: 322-334.","journal-title":"Cell Physiol Biochem"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","volume":"103","author":"Davis RJ","year":"2000","unstructured":"Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell, 2000, 103: 239-252.","journal-title":"Cell"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"Cuadrado A","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J, 2010, 429: 403-417.","journal-title":"Biochem J"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","volume":"270","author":"Xia Z","year":"1995","unstructured":"Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 1995, 270: 1326-1331.","journal-title":"Science"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/7B398A01C0AE4BAC9EFB8BF752B289B8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026048","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/7B398A01C0AE4BAC9EFB8BF752B289B8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:56:18Z","timestamp":1785815778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":69,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4,7]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2026048","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}